CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer and triple ne ...
Phase 1
Gilbert, Arizona, United States and 8 other locations
To evaluate the efficacy of cryoablation without lumpectomy and its impact on local and distant recurrence of early stage breast cancer...
Glendale, Arizona, United States and 18 other locations
This study will be conducted in patients with metastatic breast cancer who have specific Fibroblast Growth Factor Receptor gene abn...
Phase 2
Phoenix, Arizona, United States and 36 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Chandler, Arizona, United States and 226 other locations
This study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast...
Phase 2
Gilbert, Arizona, United States and 61 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Phoenix, Arizona, United States and 50 other locations
This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal (still having periods) women with ER+/HER2- breast...
Phase 2
Phoenix, Arizona, United States and 7 other locations
mg in postmenopausal women with oestrogen receptor positive advanced breast cancer who have failed on a previous endocrine treatmen...
Phase 3
Casa Grande, Arizona, United States and 102 other locations
This is a multicenter, Phase 1b-2 study of elacestrant in combination with onapristone in patients with advanced/metastatic ER+/PgR+/HER2- breast...
Phase 1, Phase 2
Phoenix, Arizona, United States and 2 other locations
of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple negative breast...
Phase 2
Chandler, Arizona, United States and 23 other locations
Clinical trials
Research sites
Resources
Legal